Report Detail

Biotechnology Global Meningococcal Vaccine Market, 2021-2027

  • RnM4343763
  • |
  • 22 September, 2021
  • |
  • Global
  • |
  • 85 Pages
  • |
  • Gen Consulting Company
  • |
  • Biotechnology

Part 1. Introduction

  • 1.1 Market Definition
  • 1.2 Key Benefit
  • 1.3 Market Segment

Part 2. Methodology

  • 2.1 Primary
  • 2.2 Secondary

Part 3. Executive Summary

    Part 4. Market Overview

    • 4.1 Introduction
    • 4.2 Market Size and Forecast
    • 4.3 Market Dynamics
      • 4.3.1 Drivers
      • 4.3.2 Restraints
    • 4.4 Impact of COVID-19 Pandemic

    Part 5. Global Market for Meningococcal Vaccine by Serotype

    • 5.1 Mena Vaccine
      • 5.1.1 Market Size and Forecast
    • 5.2 Menac Vaccine
      • 5.2.1 Market Size and Forecast
    • 5.3 Menacyw Vaccine
      • 5.3.1 Market Size and Forecast
    • 5.4 Menb/Bc Vaccine
      • 5.4.1 Market Size and Forecast
    • 5.5 Menc Vaccine
      • 5.5.1 Market Size and Forecast

    Part 6. Global Market for Meningococcal Vaccine by Vaccine Type

    • 6.1 Conjugate Meningococcal Vaccines
      • 6.1.1 Market Size and Forecast
    • 6.2 Polysaccharide Vaccine
      • 6.2.1 Market Size and Forecast
    • 6.3 Subcapsular Vaccines
      • 6.3.1 Market Size and Forecast

    Part 7. Global Market for Meningococcal Vaccine by End User

    • 7.1 Adults
      • 7.1.1 Market Size and Forecast
    • 7.2 Pediatrics
      • 7.2.1 Market Size and Forecast
    • 7.3 Travelers
      • 7.3.1 Market Size and Forecast

    Part 8. Global Market for Meningococcal Vaccine by Region

    • 8.1 Asia-Pacific
      • 8.1.1 Market Size and Forecast
    • 8.2 Europe
      • 8.2.1 Market Size and Forecast
    • 8.3 North America
      • 8.3.1 Market Size and Forecast
    • 8.4 Middle East And Africa (Mea)
      • 8.4.1 Market Size and Forecast
    • 8.5 South America
      • 8.5.1 Market Size and Forecast

    Part 9. Key Competitor Profiles

    • 9.1 GlaxoSmithKline Plc.
    • 9.2 Hualan Biological Engineering Inc.
    • 9.3 Pfizer inc.
    • 9.4 Sanofi S.A.

    *LIST IS NOT EXHAUSTIVE

      Part 10. Patent Analysis

      • 10.1 Patent Statistics
      • 10.2 Regional Analysis
      • 10.3 Trends Analysis

      DISCLAIMER

        ABOUT GEN CONSULTING COMPANY

        The global meningococcal vaccine market is projected to grow at a compound annual growth rate (CAGR) of 8.45% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.

        The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global meningococcal vaccine market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

        The meningococcal vaccine market is segmented on the basis of serotype, vaccine type, end user, and region. The meningococcal vaccine market is segmented as below:

        By Serotype:
        - MenA vaccine
        - MenAC vaccine
        - MenACYW vaccine
        - MenB/BC vaccine
        - MenC vaccine

        By Vaccine Type:
        - conjugate meningococcal vaccines
        - polysaccharide vaccine
        - subcapsular vaccines

        By End User:
        - adults
        - pediatrics
        - travelers

        By Region:
        - region
        - Asia-Pacific
        - Europe
        - North America
        - Middle East and Africa (MEA)
        - South America

        The market research report covers the analysis of key stake holders of the meningococcal vaccine market. Some of the leading players profiled in the report include GlaxoSmithKline Plc., Hualan Biological Engineering Inc., Pfizer inc., Sanofi S.A., among others.
        *list is not exhaustive, request free sample to get a complete list of companies

        Historical & Forecast Period
        This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

        Scope of the Report
        - To analyze and forecast the market size of the global meningococcal vaccine market.
        - To classify and forecast the global meningococcal vaccine market based on serotype, vaccine type, end user, and region.
        - To identify drivers and challenges for the global meningococcal vaccine market.
        - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global meningococcal vaccine market.
        - To conduct pricing analysis for the global meningococcal vaccine market.
        - To identify and analyze the profile of leading players operating in the global meningococcal vaccine market.

        Why Choose This Report
        - Gain a reliable outlook of the global meningococcal vaccine market forecasts from 2021 to 2027 across scenarios.
        - Identify growth segments for investment.
        - Stay ahead of competitors through company profiles and market data.
        - The market estimate for ease of analysis across scenarios in Excel format.
        - Strategy consulting and research support for three months.
        - Print authentication provided for the single-user license.


        Summary:
        Get latest Market Research Reports on Meningococcal Vaccine. Industry analysis & Market Report on Meningococcal Vaccine is a syndicated market report, published as Global Meningococcal Vaccine Market, 2021-2027. It is complete Research Study and Industry Analysis of Meningococcal Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $1,220.00
        $1,830.00
        $2,440.00
        884.50
        1,326.75
        1,769.00
        1,046.76
        1,570.14
        2,093.52
        139,372.80
        209,059.20
        278,745.60
        91,658.60
        137,487.90
        183,317.20
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report